Skip to content

Protected: Studies

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects with Progressive Multiple Sclerosis #NN102

Calendar Name NN102 Sprint MS
Description A study exploring the use of an unapproved drug,Ibudilast,in Primary or Secondary MS which currently there are no effective tx. for.
PI Joy Derwenskus
People Bartosz Jacher | Elizabeth Kidd
Business Administrator -
Resources 3T Trio
IRB
Start Date 2014-01-01
End Date 2017-06-30
Chart String 6405210600600
Affiliates No